PD-1 inhibitor

You have access
Comparison of Baseline ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib
Meiqi Wu, Yanyu Wang, Qiao Yang, Xuezhu Wang, Xu Yang, Haiqun Xing, Xinting Sang, Xiang Li, Haitao Zhao and Li Huo

Journal of Nuclear Medicine October 1, 2023, 64 (10) 1532-1539; DOI: https://doi.org/10.2967/jnumed.123.265712
You have access
Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non–Small Cell Lung Cancer: Comparison of Assessment Methods
Narjess Ayati, Sze Ting Lee, S. Rasoul Zakavi, Melissa Cheng, W.F. Eddie Lau, Sagun Parakh, Kunthi Pathmaraj and Andrew M. Scott

Journal of Nuclear Medicine July 1, 2021, 62 (7) 926-933; DOI: https://doi.org/10.2967/jnumed.120.254508

Main menu